/

Mechanism Of Action (MOA) Animation

Oncology MOD and MOA Animation

Created for Exelixis, Inc

The project

We created this combination MOD-MOA animation to drive awareness and interest in a new investigational compound, the multi-receptor tyrosine kinase (RTK) inhibitor zanzalintinib. Our team took a deep dive into RTK signaling in cancer to emphasize the rigorous scientific evidence backing the zanzalintinib clinical program—a primary goal for our client. The animation won the AMI Award of Excellence in 2022.

Created for
Exelixis, Inc

More

Mechanism Of Action (MOA) Animation

Still image from the Certepetide MOA animation showing a solid tumor growing.

Scientific Animation: Certepetide MOA

Lisata Therapeutics

Title slide from zanzalintinib (XL092) mechanism of action (MOA) animation. XL092 is a small-molecule inhibitor of multiple receptor tyrosine kinases (RTKs) that are involved in cancer growth and immune regulation. Animation is divided into chapters. A web-based interactive version of the video was developed for use at congresses. Animation launched at AACR 2022.

Oncology MOD and MOA Animation

Exelixis, Inc

Still image of ZORYVE (roflumilast) cream on a skin cube from a plaque psoriasis drug MOA animation.

Plaque Psoriasis Drug MOA Animation

Arcutis Biotherapeutics

Still image of the CMB complex from a cancer pathway MOD/MOA animation.

Medical Animation: Cancer Small Molecule MOA

Exelixis, Inc.

axs-studio-medical-animation-cancer-moa-xb002-01

Medical Animation: Cancer ADC MOA

Exelixis, Inc.

axs-studio-medical-animation-melanoma-BRAF-MOA-01b

Medical Animation: BRAF Inhibitor for Melanoma

Biopharmaceutical client

axs-studio-medical-animation-hodgkin-lymphoma-immunotherapy-MOA-Reed-Sternberg-cell

Hodgkin Lymphoma Immunotherapy Animation

Biopharmaceutical client

axs-studio-medical-animation-antibody-drug-conjugate-endocytosis

Medical Animation: Immuno-Oncology ADC MOA

Biopharmaceutical client

axs-studio-medical-animation-oncology-immunotherapy-trojan

Medical Animation: Cancer Immunotherapy MOA

Biopharmaceutical client

axs-studio-medical-animation-osteoporosis-drug-MOA-01

Osteoporosis Animation: Sclerostin Inhibitor MOA

Biopharmaceutical client

axs-studio-medical-animation-ldl-recector-mab

Medical Animation: PCSK9 LDL Cholesterol Regulation MOA

Biopharmaceutical Client

axs-studio-cystic-fibrosis-mechanism-of-disease-mod-animation-01

Cystic Fibrosis Animation

Vertex Pharmaceuticals; BioScience Communications